GlassScriptPhysician profile
Aleksandr Ilyayev
NPI 1962478438
$3,327.01
in general payments reported to CMS, 2019-2025
12 companies · $387 in 2025
The $387 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,223 · 2020: $418 · 2021: $245 · 2022: $250 · 2023: $299 · 2024: $505 · 2025: $387.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,191.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,190.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,504.74 | 2019-2024 | Jardiance |
| Amgen INC. | $396.55 | 2019-2025 | Otezla |
| Gilead Sciences, INC. | $362.03 | 2019-2024 | Epclusa |
| Novo Nordisk INC | $357.18 | 2021-2025 | Ozempic |
| Beigene USA, INC. | $150.00 | 2023 | Brukinsa |
| Phathom Pharmaceuticals, INC. | $125.00 | 2024 | Voquezna |
| Lilly USA, LLC | $125.00 | 2025 | Zepbound |
| Pharmacosmos Therapeutics INC. | $125.00 | 2023 | Monoferric |
| Redhill Biopharma INC. | $124.99 | 2022 | |
| Nestle Healthcare Nutrition INC. | $24.17 | 2023 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $17.67 | 2020 | |
| Aimmune Therapeutics, INC. | $14.68 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aleksandr Ilyayev listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.